Study on Therapy of Non-invasive Prolactinoma

• Status: Recruiting
• Trial end date: 2025-12-31
• Target enrollment: 0
• Participant gender: All

Summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital, Sun Yat-Sen University
• Treatments: Dopamine; Dopamine Agents; Dopamine Agonists

Criteria

Inclusion Criteria:

non-invasive prolactionma

Exclusion Criteria:

invasive prolactioma